Cargando…
A new complementary procedure for patients affected by head and neck cancer: Chemo-predictive assay
INTRODUCTION: Administration of ineffective anticancer therapy is associated with unnecessary toxicity and development of resistant clones. Cancer stem cells (CSCs) resist chemotherapy, thereby causing relapse of the disease. Thus, development of a test that identifies the most effective chemotherap...
Autores principales: | Cortese, Antonio, Pantaleo, Giuseppe, Amato, Massimo, Lawrence, Logan, Mayes, Veronica, Brown, Linda, Sarno, Maria Rosaria, Valluri, Jagan, Claudio, Pier Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963245/ https://www.ncbi.nlm.nih.gov/pubmed/27449762 http://dx.doi.org/10.1016/j.ijscr.2016.07.013 |
Ejemplares similares
-
Chemo-Predictive Assay for Targeting Cancer Stem-Like Cells in Patients Affected by Brain Tumors
por: Mathis, Sarah E., et al.
Publicado: (2014) -
Cancer Stem Cell Assay for the Treatment of Platinum-Resistant Recurrent Ovarian Cancer
por: Howard, Candace M, et al.
Publicado: (2021) -
Clinical relevance of cancer stem cell chemotherapeutic assay for recurrent ovarian cancer()
por: Howard, Candace M., et al.
Publicado: (2020) -
Minimally Manipulative Method for the Expansion of Human Bone Marrow Mesenchymal Stem Cells to Treat Osseous Defects
por: Lawrence, Logan M., et al.
Publicado: (2019) -
Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients
por: Howard, Candace M., et al.
Publicado: (2017)